These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 22107829

  • 1. Ets-1 activates overexpression of JunB and CD30 in Hodgkin's lymphoma and anaplastic large-cell lymphoma.
    Watanabe M, Itoh K, Togano T, Kadin ME, Watanabe T, Higashihara M, Horie R.
    Am J Pathol; 2012 Feb; 180(2):831-8. PubMed ID: 22107829
    [Abstract] [Full Text] [Related]

  • 2. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma.
    Watanabe M, Sasaki M, Itoh K, Higashihara M, Umezawa K, Kadin ME, Abraham LJ, Watanabe T, Horie R.
    Cancer Res; 2005 Sep 01; 65(17):7628-34. PubMed ID: 16140928
    [Abstract] [Full Text] [Related]

  • 3. Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma.
    Watanabe M, Ogawa Y, Itoh K, Koiwa T, Kadin ME, Watanabe T, Okayasu I, Higashihara M, Horie R.
    Lab Invest; 2008 Jan 01; 88(1):48-57. PubMed ID: 17965727
    [Abstract] [Full Text] [Related]

  • 4. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.
    Hsu FY, Johnston PB, Burke KA, Zhao Y.
    Cancer Res; 2006 Sep 15; 66(18):9002-8. PubMed ID: 16982741
    [Abstract] [Full Text] [Related]

  • 5. The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling.
    Staber PB, Vesely P, Haq N, Ott RG, Funato K, Bambach I, Fuchs C, Schauer S, Linkesch W, Hrzenjak A, Dirks WG, Sexl V, Bergler H, Kadin ME, Sternberg DW, Kenner L, Hoefler G.
    Blood; 2007 Nov 01; 110(9):3374-83. PubMed ID: 17690253
    [Abstract] [Full Text] [Related]

  • 6. The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma.
    Atsaves V, Lekakis L, Drakos E, Leventaki V, Ghaderi M, Baltatzis GE, Chioureas D, Jones D, Feretzaki M, Liakou C, Panayiotidis P, Gorgoulis V, Patsouris E, Medeiros LJ, Claret FX, Rassidakis GZ.
    Br J Haematol; 2014 Nov 01; 167(4):514-23. PubMed ID: 25145835
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. NPM-ALK and the JunB transcription factor regulate the expression of cytotoxic molecules in ALK-positive, anaplastic large cell lymphoma.
    Pearson JD, Lee JK, Bacani JT, Lai R, Ingham RJ.
    Int J Clin Exp Pathol; 2011 Jan 30; 4(2):124-33. PubMed ID: 21326808
    [Abstract] [Full Text] [Related]

  • 9. The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-kappaB activation in anaplastic large cell lymphoma.
    Horie R, Watanabe M, Ishida T, Koiwa T, Aizawa S, Itoh K, Higashihara M, Kadin ME, Watanabe T.
    Cancer Cell; 2004 Apr 30; 5(4):353-64. PubMed ID: 15093542
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The c-Jun and JunB transcription factors facilitate the transit of classical Hodgkin lymphoma tumour cells through G1.
    Zhang J, Wu Z, Savin A, Yang M, Hsu YR, Jantuan E, Bacani JTC, Ingham RJ.
    Sci Rep; 2018 Oct 30; 8(1):16019. PubMed ID: 30375407
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Abnormal activator protein 1 transcription factor expression in CD30-positive cutaneous large-cell lymphomas.
    Mao X, Orchard G, Russell-Jones R, Whittaker S.
    Br J Dermatol; 2007 Nov 30; 157(5):914-21. PubMed ID: 17725669
    [Abstract] [Full Text] [Related]

  • 14. Constitutive control of AKT1 gene expression by JUNB/CJUN in ALK+ anaplastic large-cell lymphoma: a novel crosstalk mechanism.
    Atsaves V, Zhang R, Ruder D, Pan Y, Leventaki V, Rassidakis GZ, Claret FX.
    Leukemia; 2015 Nov 30; 29(11):2162-72. PubMed ID: 25987255
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease.
    Wellmann A, Otsuki T, Vogelbruch M, Clark HM, Jaffe ES, Raffeld M.
    Blood; 1995 Sep 15; 86(6):2321-8. PubMed ID: 7662979
    [Abstract] [Full Text] [Related]

  • 18. JunB expression is a common feature of CD30+ lymphomas and lymphomatoid papulosis.
    Rassidakis GZ, Thomaides A, Atwell C, Ford R, Jones D, Claret FX, Medeiros LJ.
    Mod Pathol; 2005 Oct 15; 18(10):1365-70. PubMed ID: 15920551
    [Abstract] [Full Text] [Related]

  • 19. AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells.
    Watanabe M, Ogawa Y, Ito K, Higashihara M, Kadin ME, Abraham LJ, Watanabe T, Horie R.
    Am J Pathol; 2003 Aug 15; 163(2):633-41. PubMed ID: 12875982
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.